Literature DB >> 7012244

Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths.

O Sonnabend, W Sonnabend, R Heinzle, T Sigrist, R Dirnhofer, U Krech.   

Abstract

Clostridium botulinum type G has not been identified until now from humans or animals; it has been isolated only twice, from soil samples in Argentina. Type G organisms were isolated from necropsy specimens in four adults and an 18-week-old infant. Type G botulinal toxin was demonstrated in the serum of three of these individuals. The toxic dose in mice ranged from 2 to 7 50% lethal doses/ml. These persons died suddenly and unexpectedly at home, without any pathologic evidence to account for the cause of death in four cases. Symptoms in two individuals were similar to those observed in food-borne botulism. Thus, a prompt postmortem search for toxin and organisms of C. Botulinum in blood and feces may be worthwhile in determining the etiology of unexplained deaths. More microbiologic, physiologic, and toxicologic data are needed to clarify the role of C. botulinum in the pathogenesis of sudden unexpected death in infants and adults.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7012244     DOI: 10.1093/infdis/143.1.22

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  29 in total

1.  Detection and confirmation of Clostridium botulinum in water used for cooling at a plant producing low-acid canned foods.

Authors:  Amita Sachdeva; Stephanie L H Defibaugh-Chávez; James B Day; Donald Zink; Shashi K Sharma
Journal:  Appl Environ Microbiol       Date:  2010-10-01       Impact factor: 4.792

2.  Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.

Authors:  K K Hill; T J Smith; C H Helma; L O Ticknor; B T Foley; R T Svensson; J L Brown; E A Johnson; L A Smith; R T Okinaka; P J Jackson; J D Marks
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

3.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Wound botulism complicating internal fixation of a complex radial fracture.

Authors:  Steve M Taylor; Cameron R Wolfe; Terry C Dixon; David S Ruch; Gary M Cox
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

Review 5.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G.

Authors:  M W Eklund; F T Poysky; L M Mseitif; M S Strom
Journal:  Appl Environ Microbiol       Date:  1988-06       Impact factor: 4.792

7.  Multilocus enzyme electrophoresis of Clostridium argentinense (Clostridium botulinum toxin type G) and phenotypically similar asaccharolytic clostridia.

Authors:  M Altwegg; C L Hatheway
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

8.  The genes for the Clostridium botulinum type G toxin complex are on a plasmid.

Authors:  Y Zhou; H Sugiyama; H Nakano; E A Johnson
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes.

Authors:  Theresa J Smith; Karen K Hill; Gary Xie; Brian T Foley; Charles H D Williamson; Jeffrey T Foster; Shannon L Johnson; Olga Chertkov; Hazuki Teshima; Henry S Gibbons; Lauren A Johnsky; Mark A Karavis; Leonard A Smith
Journal:  Infect Genet Evol       Date:  2014-12-06       Impact factor: 3.342

10.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.